Crocs CEO Andrew Rees’s trust sells 40,000 shares

Q: How many CROX shares did Andrew Rees’s trust sell, and at what prices?

The trust sold 40,000 Crocs common shares on November 3, 2026, in three transactions: 18,049 at a weighted average of $152.2450 per share (range $151.67–$152.66), 17,251 at $153.2782 ($152.67–$153.57), and 4,700 at $153.9411 ($153.78–$154.08). No Rule 10b5-1 plan is reported.

Q: Who held the CROX shares sold by Andrew Rees?

The shares were held by the REES FAMILY LIVING TRUST U/A DTD 03/22/2019. Andrew Rees, Crocs’ Chief Executive Officer, is a trustee and exercises voting and investment power for shares beneficially owned by the trust.

Q: How many CROX shares did Andrew Rees hold directly?

The report lists Andrew Rees as directly holding 570,179 Crocs common shares on November 3, 2026.

The three reported sale tranches involved shares held by a family trust whose trustee exercises voting and investment power over them.

Available on EDGAR 11/05/2026 - 04:38 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:37 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Crocs, Inc. Chief Executive Officer Andrew Rees reported three sales by the REES FAMILY LIVING TRUST on November 3, 2026, totaling 40,000 common shares. The trust sold 18,049 shares at a weighted average of $152.2450 per share, 17,251 at $153.2782 per share, and 4,700 at $153.9411 per share. Rees is the trust’s trustee and exercises voting and investment power over its shares. Separately, the report lists 570,179 shares held directly by Rees. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 40,000 shares

Net Sell 3 txns

Insider Rees Andrew

Role Chief Executive Officer

Sold 40,000 shs ($6.12M)

Share of Position Sold 5.6%

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	18,049	$152.245	$2.75M
Sale	Common Stock ^{F3, F2}	17,251	$153.2782	$2.64M
Sale	Common Stock ^{F4, F2}	4,700	$153.9411	$724K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 673,293 shares (Indirect, By Trust); Common Stock — 570,179 shares (Direct)

Holdings Before and After: Common Stock, 713,293 to 673,293 shares (Indirect, By Trust)

Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

F1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.67 - $152.66, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.
F2. The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.
F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.67 to $153.57, inclusive.
F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.78 to $154.08, inclusive.

Key Figures

Shares sold by trust: 40,000 shares Shares sold, first transaction: 18,049 shares Weighted average price, first transaction: $152.2450 per share +5 more

8 metrics

Shares sold by trust 40,000 shares Three sales reported for November 3, 2026

Shares sold, first transaction 18,049 shares Trust sale on November 3, 2026

Weighted average price, first transaction $152.2450 per share Trust sale; prices ranged from $151.67 to $152.66

Shares sold, second transaction 17,251 shares Trust sale on November 3, 2026

Weighted average price, second transaction $153.2782 per share Trust sale; prices ranged from $152.67 to $153.57

Shares sold, third transaction 4,700 shares Trust sale on November 3, 2026

Weighted average price, third transaction $153.9411 per share Trust sale; prices ranged from $153.78 to $154.08

Direct shares held by Andrew Rees 570,179 shares Reported on November 3, 2026

Key Terms

weighted average price, beneficially owned, voting and investment power

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficially owned regulatory

"shares beneficially owned by the trust"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

voting and investment power regulatory

"exercises voting and investment power for the shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CROX shares did Andrew Rees’s trust sell, and at what prices?

The trust sold 40,000 Crocs common shares on November 3, 2026, in three transactions: 18,049 at a weighted average of $152.2450 per share (range $151.67–$152.66), 17,251 at $153.2782 ($152.67–$153.57), and 4,700 at $153.9411 ($153.78–$154.08). No Rule 10b5-1 plan is reported.

Who held the CROX shares sold by Andrew Rees?

The shares were held by the REES FAMILY LIVING TRUST U/A DTD 03/22/2019. Andrew Rees, Crocs’ Chief Executive Officer, is a trustee and exercises voting and investment power for shares beneficially owned by the trust.

How many CROX shares did Andrew Rees hold directly?

The report lists Andrew Rees as directly holding 570,179 Crocs common shares on November 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rees Andrew

(Last)

(First)

(Middle)

C/O CROCS, INC.

500 ELDORADO BLVD #5

(Street)

BROOMFIELD

COLORADO

80021

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/03/2026		S		18,049	D	$152.245⁽¹⁾	695,244	I	By Trust⁽²⁾
Common Stock	11/03/2026		S		17,251	D	$153.2782⁽³⁾	677,993	I	By Trust⁽²⁾
Common Stock	11/03/2026		S		4,700	D	$153.9411⁽⁴⁾	673,293	I	By Trust⁽²⁾
Common Stock								570,179	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.67 - $152.66, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.

2. The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.67 to $153.57, inclusive.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.78 to $154.08, inclusive.

Remarks:

	/s/Sara Hoverstock, Attorney-in-Fact	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR